Trial intelligence / Profile preview

Minoxidil vs Minoxidil + Finasteride in Androgenetic Alopecia

NCT01391156Phase 3Completed

Sponsor
Mae Fah Luang University Hospital
Start
Mar 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of DA-4001C in androgenetic alopecia (AGA) (2 arms), sponsored by Mae Fah Luang University Hospital. Primary endpoint: Mean change of hair count at 6 months. Started Mar 2011; status: completed.

02

Drugs

DA-4001C
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT01391156.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01391156.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call